Cornovus Pharmaceuticals' Unattributed Round

Cornovus Pharmaceuticals raised a round of funding on March 03, 2014.

Cornovus Pharmaceuticals has identified a new target and class of agents to treat cardiac failure. The technology, which has been proven in mouse models, delays the onset of heart failure after a hear…

Articles about Cornovus Pharmaceuticals' Unattributed Round: